Literature DB >> 20190016

A synonymous mutation in the CFTR gene causes aberrant splicing in an italian patient affected by a mild form of cystic fibrosis.

Valeria Faa'1, Alessandra Coiana, Federica Incani, Lucy Costantino, Antonio Cao, Maria Cristina Rosatelli.   

Abstract

Mutations within exons are responsible for aberrant splicing of pre-mRNA in several human disease genes and in some viral systems. Nonsense, missense, and even synonymous mutations can induce aberrant skipping of the mutant exon, producing nonfunctional proteins. In this paper, we describe the effect on the splicing efficiency of the synonymous variant 2811 G>T [Gly893Gly] detected in a patient of Italian descent affected by a mild form of cystic fibrosis, until now mentioned as sequence variation with unknown functional consequences. The study, performed through DNA as well as RNA analyses, shows that this mutation creates a new 5' splice site within exon 15, resulting in a transcript lacking 76 amino acid residues. Although this aberrant splicing causes a shorter exon 15, the downstream exonic sequence from exon 16 to the end of the open reading frame is in frame. This study indicates that apparently neutral polymorphism, which may be erroneously classified as nonpathogenic, may indeed led to aberrant splicing thereby resulting in defective protein.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20190016      PMCID: PMC2860476          DOI: 10.2353/jmoldx.2010.090126

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  25 in total

1.  An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN.

Authors:  C L Lorson; E J Androphy
Journal:  Hum Mol Genet       Date:  2000-01-22       Impact factor: 6.150

2.  SR proteins and hnRNP H regulate the splicing of the HIV-1 tev-specific exon 6D.

Authors:  Massimo Caputi; Alan M Zahler
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

3.  A "G" to "A" mutation at position -1 of a 5' splice site in a late infantile form of Tay-Sachs disease.

Authors:  S Akli; J Chelly; C Mezard; S Gandy; A Kahn; L Poenaru
Journal:  J Biol Chem       Date:  1990-05-05       Impact factor: 5.157

Review 4.  Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening.

Authors:  Joseph L Bobadilla; Milan Macek; Jason P Fine; Philip M Farrell
Journal:  Hum Mutat       Date:  2002-06       Impact factor: 4.878

5.  Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1.

Authors:  Luca Cartegni; Adrian R Krainer
Journal:  Nat Genet       Date:  2002-03-04       Impact factor: 38.330

6.  A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy.

Authors:  Tsuyoshi Kashima; James L Manley
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

7.  Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene.

Authors:  Isabel Aznarez; Elayne M Chan; Julian Zielenski; Benjamin J Blencowe; Lap-Chee Tsui
Journal:  Hum Mol Genet       Date:  2003-08-15       Impact factor: 6.150

8.  Characterization of a disease-associated mutation affecting a putative splicing regulatory element in intron 6b of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Authors:  Valeria Faà; Federica Incani; Alessandra Meloni; Denise Corda; Maddalena Masala; A Maria Baffico; Manuela Seia; Antonio Cao; M Cristina Rosatelli
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

9.  Missense, nonsense, and neutral mutations define juxtaposed regulatory elements of splicing in cystic fibrosis transmembrane regulator exon 9.

Authors:  Franco Pagani; Emanuele Buratti; Cristiana Stuani; Francisco E Baralle
Journal:  J Biol Chem       Date:  2003-05-05       Impact factor: 5.157

10.  New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon 12.

Authors:  Franco Pagani; Cristiana Stuani; Maria Tzetis; Emmanuel Kanavakis; Alexandra Efthymiadou; Stavros Doudounakis; Teresa Casals; Francisco E Baralle
Journal:  Hum Mol Genet       Date:  2003-05-15       Impact factor: 6.150

View more
  11 in total

Review 1.  Computational approaches to study the effects of small genomic variations.

Authors:  Kamil Khafizov; Maxim V Ivanov; Olga V Glazova; Sergei P Kovalenko
Journal:  J Mol Model       Date:  2015-09-08       Impact factor: 1.810

2.  Functional analysis of synonymous substitutions predicted to affect splicing of the CFTR gene.

Authors:  Alexandra Scott; Hanna M Petrykowska; Timothy Hefferon; Valer Gotea; Laura Elnitski
Journal:  J Cyst Fibros       Date:  2012-05-14       Impact factor: 5.482

3.  Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men.

Authors:  Inik Chang; Shinichiro Fukuhara; Darryn K Wong; Ankurpreet Gill; Yozo Mitsui; Shahana Majid; Sharanjot Saini; Soichiro Yamamura; Takeshi Chiyomaru; Hiroshi Hirata; Koji Ueno; Sumit Arora; Varahram Shahryari; Guoren Deng; Z Laura Tabatabai; Kirsten L Greene; Dong Min Shin; Hideki Enokida; Hiroaki Shiina; Norio Nonomura; Rajvir Dahiya; Yuichiro Tanaka
Journal:  Tumour Biol       Date:  2014-07-17

Review 4.  The cystic fibrosis gene: a molecular genetic perspective.

Authors:  Lap-Chee Tsui; Ruslan Dorfman
Journal:  Cold Spring Harb Perspect Med       Date:  2013-02-01       Impact factor: 6.915

Review 5.  A review of gigaxonin mutations in giant axonal neuropathy (GAN) and cancer.

Authors:  James J Kang; Isabelle Y Liu; Marilene B Wang; Eri S Srivatsan
Journal:  Hum Genet       Date:  2016-03-29       Impact factor: 4.132

Review 6.  RNA-Binding Proteins: Splicing Factors and Disease.

Authors:  Alger M Fredericks; Kamil J Cygan; Brian A Brown; William G Fairbrother
Journal:  Biomolecules       Date:  2015-05-13

7.  Mutational analysis and genotype-phenotype correlations in southern Indian patients with sporadic and familial aniridia.

Authors:  Sushil Kumar Dubey; Nagasubramanian Mahalaxmi; Perumalsamy Vijayalakshmi; Periasamy Sundaresan
Journal:  Mol Vis       Date:  2015-01-27       Impact factor: 2.367

8.  Widespread position-specific conservation of synonymous rare codons within coding sequences.

Authors:  Julie L Chaney; Aaron Steele; Rory Carmichael; Anabel Rodriguez; Alicia T Specht; Kim Ngo; Jun Li; Scott Emrich; Patricia L Clark
Journal:  PLoS Comput Biol       Date:  2017-05-05       Impact factor: 4.475

9.  Unraveling synonymous and deep intronic variants causing aberrant splicing in two genetically undiagnosed epilepsy families.

Authors:  Qiang Li; Yiting Wang; Yijun Pan; Jia Wang; Weishi Yu; Xiaodong Wang
Journal:  BMC Med Genomics       Date:  2021-06-09       Impact factor: 3.063

10.  Evaluation of both exonic and intronic variants for effects on RNA splicing allows for accurate assessment of the effectiveness of precision therapies.

Authors:  Anya T Joynt; Taylor A Evans; Matthew J Pellicore; Emily F Davis-Marcisak; Melis A Aksit; Alice C Eastman; Shivani U Patel; Kathleen C Paul; Derek L Osorio; Alyssa D Bowling; Calvin U Cotton; Karen S Raraigh; Natalie E West; Christian A Merlo; Garry R Cutting; Neeraj Sharma
Journal:  PLoS Genet       Date:  2020-10-21       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.